Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2026-05-12 @ 11:07 AM
Study NCT ID:
NCT01124734
Status:
COMPLETED
Last Update Posted:
2019-02-12
First Post:
2010-03-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma
Sponsor:
Milton S. Hershey Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PSHCI 09-067
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None